Mission

Our mission is to generate, develop and commercialize novel antibodies which target critical molecules involved in the onset and exacerbation of acute and life-threatening diseases.

We are committed to innovation in the development of diagnostic and therapeutic products which improve the health of patients while contributing to the interests of society, our collaborators, partners, and shareholders.